(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 19.98% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 6.55%.
Biodesix's revenue in 2023 is $44,026,000.On average, 2 Wall Street analysts forecast BDSX's revenue for 2023 to be $4,539,195,720, with the lowest BDSX revenue forecast at $4,523,814,750, and the highest BDSX revenue forecast at $4,554,667,167. On average, 2 Wall Street analysts forecast BDSX's revenue for 2024 to be $5,680,825,610, with the lowest BDSX revenue forecast at $5,564,292,143, and the highest BDSX revenue forecast at $5,797,449,555.
In 2025, BDSX is forecast to generate $7,007,298,571 in revenue, with the lowest revenue forecast at $7,007,298,571 and the highest revenue forecast at $7,007,298,571.